is being presented by Dr Pete Harpum, Harpum Consulting and airs on Thursday, March 22nd, 2012. For more details or to register, please visit our site at www.fxconferences.com
The focus of work in the drug development industry is inexorably moving away from vertically integrated pharmaceutical and biotechnology companies – the ‘sponsors’ – to contract research organizations (CROs) and other third-party suppliers of services. Approximately 350,000 people have left employment in pharmaceutical and biotechnology companies – but they did not leave the industry. Many of these people moved from the sponsor/client side to the CRO/seller side. Drug development work is now increasingly done by third parties: the challenge facing industry is how to maintain and improve quality of service?
Partnering is a valuable strategy for clients and sellers to work together. In this presentation our speaker draws upon the lessons of other industries in which the majority of work is carried out by third parties in partnership with buyers, and looks at how partnering can facilitate high quality service provision by CROs.
